Flu for all
Executive Summary
Centers for Disease Control and Prevention allows healthy persons to receive flu vaccine beginning in October. Due to supply problems in recent seasons, CDC had required tiered immunization, with high-risk patients receiving product first. A sufficient supply of vaccine will be available this season. MedImmune and Wyeth expected early availability of FluMist to provide an advantage over other vaccines that have typically been bound to tiered immunization (1"The Pink Sheet" Aug. 4, 2003, p. 26)...
You may also be interested in...
FluMist Arriving Ahead Of Schedule; Could Aid Sales, MedImmune Says
MedImmune has begun shipping the first 500,000 doses of the nasal flu vaccine FluMist
US FDA Drugs Center Ready To Break Down Silos On Regulatory Innovation
CDER Director Cavazzoni is promising to increase coordination and collaboration to accelerate broader adoption of innovative clinical trial designs and other approaches to speed drug development. A new "Quantitative Medicine Center of Excellence" illustrates the approach.
New OSP Director To Guide CDER-Wide IT Upgrades; System Enhancements Speed ANDA Assessments
Generic Drug Structured Assessment for Bioequivalence launched in 2023 and has been used in 40 ANDA reviews so far.